Live
AgilentAgilent Technologies (A) Announces Transition of Chief Legal Off - GuruFocusAgilentHow Investors May Respond To Agilent Technologies (A) CRISPR Patent Setback And New BioTek Cytation 9 Launch - Yahoo FinanceAgilentAgilent Technologies announces transition of chief legal officer Bret DiMarco - investing.comAgilentAgilent (NYSE: A) details Chief Legal Officer transition and advisory role - Stock TitanIlluminaCathie Wood's Called It Years Ago – Illumina Is the Must-Own Personalized Biotech Stock - Money MorningFierceBiotechTrump slaps 100% duties on imported drugs but leaves plenty of exceptionsFierceBiotechBiopharma R&D pipeline shrinks for 1st time in 30 years: reportFierceBiotechADCs, TCEs among ‘exciting things’ on Boehringer’s dealmaking shopping listFierceBiotechMonths after $100M series A, Syneron closes $150M round to support peptide platformBioPharma DiveTrump revives pharma tariffs with 100% charges, but leaves loopholesPLoS BiologyHow the brain copes with bad timesThermo FisherThermo Fisher Scientific introduces Gibco™ CTS™ Compleo™ Fill and Finish System - BioSpectrum Asia
BioWorld Feb 11, 2026

Tempest Therapeutics outlines plans for acquired CAR T assets

Tempest Therapeutics outlines plans for acquired CAR T assets

Original
Body unavailable. Use the original source.

Directory

59 All